ロード中...
Ceftazidime‐Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups
Ceftazidime‐avibactam is a novel β‐lactam/β‐lactamase inhibitor combination for the treatment of serious infections caused by resistant gram‐negative pathogens. Population pharmacokinetic (PopPK) models were built to incorporate pharmacokinetic (PK) data from five phase III trials in patients with c...
保存先:
| 出版年: | Clin Transl Sci |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6440567/ https://ncbi.nlm.nih.gov/pubmed/30221827 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cts.12585 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|